Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Abid Aljabri"'
Autor:
Kukuh Madyaningrana, Vijith Vijayan, Christoph Nikolin, Abid Aljabri, Srinu Tumpara, Elena Korenbaum, Harshit Shah, Metodi Stankov, Heiko Fuchs, Sabina Janciauskiene, Stephan Immenschuh
Publikováno v:
Redox Biology, Vol 46, Iss , Pp 102060- (2021)
Free heme toxicity in the vascular endothelium is critical for the pathogenesis of hemolytic disorders including sickle cell disease. In the current study, it is demonstrated that human alpha1-antitrypsin (A1AT), a serine protease inhibitor with high
Externí odkaz:
https://doaj.org/article/7ccb96f4d37c4118904fd1cf743814d1
Autor:
Eva Zilian, Hendry Saragih, Vijith Vijayan, Oliver Hiller, Constanca Figueiredo, Abid Aljabri, Rainer Blasczyk, Gregor Theilmeier, Jan Ulrich Becker, Jan Larmann, Stephan Immenschuh
Publikováno v:
PLoS ONE, Vol 10, Iss 12, p e0145306 (2015)
Antibody-mediated rejection (AMR) is a key limiting factor for long-term graft survival in solid organ transplantation. Human leukocyte antigen (HLA) class I (HLA I) antibodies (Abs) play a major role in the pathogenesis of AMR via their interactions
Externí odkaz:
https://doaj.org/article/0494895e74564509be37242004005035
Autor:
Abid Aljabri, Harshit R. Shah, Srinu Tumpara, Stephan Immenschuh, Christoph Nikolin, Sabina Janciauskiene, Elena Korenbaum, Kukuh Madyaningrana, Vijith Vijayan, Heiko R. Fuchs, Metodi V. Stankov
Publikováno v:
Redox Biology, Vol 46, Iss, Pp 102060-(2021)
Redox Biology
Redox Biology
Free heme toxicity in the vascular endothelium is critical for the pathogenesis of hemolytic disorders including sickle cell disease. In the current study, it is demonstrated that human alpha1-antitrypsin (A1AT), a serine protease inhibitor with high
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c98126ad1bae543d639d4eb909cdcb0a
http://www.sciencedirect.com/science/article/pii/S2213231721002196
http://www.sciencedirect.com/science/article/pii/S2213231721002196
Autor:
Stephan Immenschuh, Abid Aljabri, Constanca Figueiredo, Jan U. Becker, Andreas Linkermann, Vijith Vijayan, Rainer Blasczyk, Metodi V. Stankov, Christoph Nikolin
Publikováno v:
Cell Death & Disease
Web of Science
Cell Death and Disease, Vol 10, Iss 3, Pp 1-15 (2019)
Web of Science
Cell Death and Disease, Vol 10, Iss 3, Pp 1-15 (2019)
Antibody-mediated rejection (AMR) is the major cause of allograft loss after solid organ transplantation. Circulating donor-specific antibodies against human leukocyte antigen (HLA), in particular HLA class II antibodies are critical for the pathogen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a87dfe38da9651cd20e66f567d406ad1
http://europepmc.org/articles/PMC6408495
http://europepmc.org/articles/PMC6408495
Autor:
Eva Zilian, Stephan Immenschuh, Gregor Theilmeier, Oliver Hiller, Jan Larmann, Abid Aljabri, Hendry Saragih, Jan U. Becker, Constanca Figueiredo, Rainer Blasczyk
Publikováno v:
Human Immunology. 76:15
Aim Antibody-mediated rejection (AMR) is a key limiting factor for long-term graft survival in heart and kidney transplantation. Activation of endothelial cells (ECs) via complement-independent effects of human leukocyte antigen class I (HLA I) antib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f189fab77c72437e3213c1ac124a0f64
https://doi.org/10.1016/j.humimm.2015.07.023
https://doi.org/10.1016/j.humimm.2015.07.023